Global Liraglutide Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Publisher Name :
Date: 11-Jun-2018
No. of pages: 137

Liraglutide (NN2211) is a long-acting glucagon-like peptide-1 receptor agonist, binding to the same receptors as does the endogenous metabolic hormone GLP-1 that stimulates insulin secretion. Marketed under the brand name Victoza, it is an injectable drug developed by Novo Nordisk for the treatment of type 2 diabetes. In 2015, Novo Nordisk began marketing it in the U.S. under the brand name Saxenda as a treatment for obesity in adults with at least one weight-related comorbid condition.

Scope of the Report:

This report focuses on the Liraglutide in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

The total amount of Patents about Liraglutide are 1871, among those Patents, 44%is about application, 26%is about Combination therapy, and 12%is about Preparation method.

In these patents, accounting for Europe is the largest, followed by North America, and finally Asia.

The application of Liraglutide

Liraglutide for the treatment of type 2 diabetes mellitus

Liraglutide 1.2 mg daily in triple therapy regimens (in combination with metformin and a sulphonylurea, or metformin and a thiazolidinedione) is recommended as an option for the treatment of people with type 2 diabetes, only if used as described for exenatide in 'Type 2 diabetes: the management of type 2 diabetes'

Liraglutide 1.2 mg daily in dual therapy regimens (in combination with metformin or a sulphonylurea) is recommended as an option for the treatment of people with type 2 diabetes, only if the person is intolerant of either metformin or a sulphonylurea, or treatment with metformin or a sulphonylurea is contraindicated, and the person is intolerant of thiazolidinediones and dipeptidyl peptidase-4 (DPP-4) inhibitors, or treatment with thiazolidinediones and DPP-4 inhibitors is contraindicated.

Liraglutide 1.8 mg daily is not recommended for the treatment of people with type 2 diabetes.

The Committee concluded that the evidence provided was not robust enough to allow it to recommend liraglutide as a cost-effective alternative to either thiazolidinediones or DPP-4 inhibitors as a triple therapy regimen, however it believes liraglutide is a cost-effective treatment option relative to exenatide.

Taking into account the lack of clinical trial evidence showing a significant benefit from increasing the liraglutide dose from 1.2 mg to 1.8 mg, the widely varying ICERs and the uncertainty in the economic analysis, the Committee was unable to recommend liraglutide 1.8 mg for the treatment of type 2 diabetes.

The Committee concluded that people with type 2 diabetes currently receiving liraglutide who do not meet the criteria specified in section 1.1 or 1.3, or who are receiving liraglutide 1.8 mg, should have the option to continue their current treatment until they and their clinicians consider it appropriate to stop.

The worldwide market for Liraglutide is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

- HEC Pharm

- Bachem

- Bharat Pharmaceuticals

- Kingpep Biotechnology

- Shenzhen JYMed Technology

- Wuxi Asiapeptide

- AmbioPharm

Market Segment by Regions, regional analysis covers

- North America (United States, Canada and Mexico)

- Europe (Germany, France, UK, Russia and Italy)

- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

- South America (Brazil, Argentina, Colombia etc.)

- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

- Pills

- Liquid

Market Segment by Applications, can be divided into

- Hospital

- Drug Store

There are 15 Chapters to deeply display the global Liraglutide market.

Chapter 1, to describe Liraglutide Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Liraglutide, with sales, revenue, and price of Liraglutide, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Liraglutide, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Liraglutide market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Liraglutide sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Global Liraglutide Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Table of Contents

1 Market Overview
1.1 Liraglutide Introduction
1.2 Market Analysis by Type
1.2.1 Pills
1.2.2 Liquid
1.3 Market Analysis by Applications
1.3.1 Hospital
1.3.2 Drug Store
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 HEC Pharm
2.1.1 Business Overview
2.1.2 Liraglutide Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 HEC Pharm Liraglutide Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Bachem
2.2.1 Business Overview
2.2.2 Liraglutide Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Bachem Liraglutide Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Bharat Pharmaceuticals
2.3.1 Business Overview
2.3.2 Liraglutide Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Bharat Pharmaceuticals Liraglutide Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Kingpep Biotechnology
2.4.1 Business Overview
2.4.2 Liraglutide Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Kingpep Biotechnology Liraglutide Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Shenzhen JYMed Technology
2.5.1 Business Overview
2.5.2 Liraglutide Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Shenzhen JYMed Technology Liraglutide Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Wuxi Asiapeptide
2.6.1 Business Overview
2.6.2 Liraglutide Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Wuxi Asiapeptide Liraglutide Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 AmbioPharm
2.7.1 Business Overview
2.7.2 Liraglutide Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 AmbioPharm Liraglutide Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Liraglutide Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Liraglutide Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Liraglutide Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Liraglutide Manufacturer Market Share in 2017
3.3.2 Top 6 Liraglutide Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Liraglutide Market Analysis by Regions
4.1 Global Liraglutide Sales, Revenue and Market Share by Regions
4.1.1 Global Liraglutide Sales and Market Share by Regions (2013-2018)
4.1.2 Global Liraglutide Revenue and Market Share by Regions (2013-2018)
4.2 North America Liraglutide Sales and Growth Rate (2013-2018)
4.3 Europe Liraglutide Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Liraglutide Sales and Growth Rate (2013-2018)
4.5 South America Liraglutide Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Liraglutide Sales and Growth Rate (2013-2018)
5 North America Liraglutide by Countries
5.1 North America Liraglutide Sales, Revenue and Market Share by Countries
5.1.1 North America Liraglutide Sales and Market Share by Countries (2013-2018)
5.1.2 North America Liraglutide Revenue and Market Share by Countries (2013-2018)
5.2 United States Liraglutide Sales and Growth Rate (2013-2018)
5.3 Canada Liraglutide Sales and Growth Rate (2013-2018)
5.4 Mexico Liraglutide Sales and Growth Rate (2013-2018)
6 Europe Liraglutide by Countries
6.1 Europe Liraglutide Sales, Revenue and Market Share by Countries
6.1.1 Europe Liraglutide Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Liraglutide Revenue and Market Share by Countries (2013-2018)
6.2 Germany Liraglutide Sales and Growth Rate (2013-2018)
6.3 UK Liraglutide Sales and Growth Rate (2013-2018)
6.4 France Liraglutide Sales and Growth Rate (2013-2018)
6.5 Russia Liraglutide Sales and Growth Rate (2013-2018)
6.6 Italy Liraglutide Sales and Growth Rate (2013-2018)
7 Asia-Pacific Liraglutide by Countries
7.1 Asia-Pacific Liraglutide Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Liraglutide Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Liraglutide Revenue and Market Share by Countries (2013-2018)
7.2 China Liraglutide Sales and Growth Rate (2013-2018)
7.3 Japan Liraglutide Sales and Growth Rate (2013-2018)
7.4 Korea Liraglutide Sales and Growth Rate (2013-2018)
7.5 India Liraglutide Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Liraglutide Sales and Growth Rate (2013-2018)
8 South America Liraglutide by Countries
8.1 South America Liraglutide Sales, Revenue and Market Share by Countries
8.1.1 South America Liraglutide Sales and Market Share by Countries (2013-2018)
8.1.2 South America Liraglutide Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Liraglutide Sales and Growth Rate (2013-2018)
8.3 Argentina Liraglutide Sales and Growth Rate (2013-2018)
8.4 Colombia Liraglutide Sales and Growth Rate (2013-2018)
9 Middle East and Africa Liraglutide by Countries
9.1 Middle East and Africa Liraglutide Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Liraglutide Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Liraglutide Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Liraglutide Sales and Growth Rate (2013-2018)
9.3 UAE Liraglutide Sales and Growth Rate (2013-2018)
9.4 Egypt Liraglutide Sales and Growth Rate (2013-2018)
9.5 Nigeria Liraglutide Sales and Growth Rate (2013-2018)
9.6 South Africa Liraglutide Sales and Growth Rate (2013-2018)
10 Global Liraglutide Market Segment by Type
10.1 Global Liraglutide Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Liraglutide Sales and Market Share by Type (2013-2018)
10.1.2 Global Liraglutide Revenue and Market Share by Type (2013-2018)
10.2 Pills Sales Growth and Price
10.2.1 Global Pills Sales Growth (2013-2018)
10.2.2 Global Pills Price (2013-2018)
10.3 Liquid Sales Growth and Price
10.3.1 Global Liquid Sales Growth (2013-2018)
10.3.2 Global Liquid Price (2013-2018)
11 Global Liraglutide Market Segment by Application
11.1 Global Liraglutide Sales Market Share by Application (2013-2018)
11.2 Hospital Sales Growth (2013-2018)
11.3 Drug Store Sales Growth (2013-2018)
12 Liraglutide Market Forecast (2018-2023)
12.1 Global Liraglutide Sales, Revenue and Growth Rate (2018-2023)
12.2 Liraglutide Market Forecast by Regions (2018-2023)
12.2.1 North America Liraglutide Market Forecast (2018-2023)
12.2.2 Europe Liraglutide Market Forecast (2018-2023)
12.2.3 Asia-Pacific Liraglutide Market Forecast (2018-2023)
12.2.4 South America Liraglutide Market Forecast (2018-2023)
12.2.5 Middle East and Africa Liraglutide Market Forecast (2018-2023)
12.3 Liraglutide Market Forecast by Type (2018-2023)
12.3.1 Global Liraglutide Sales Forecast by Type (2018-2023)
12.3.2 Global Liraglutide Market Share Forecast by Type (2018-2023)
12.4 Liraglutide Market Forecast by Application (2018-2023)
12.4.1 Global Liraglutide Sales Forecast by Application (2018-2023)
12.4.2 Global Liraglutide Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source


List of Tables and Figures

Figure Liraglutide Picture
Table Product Specifications of Liraglutide
Figure Global Sales Market Share of Liraglutide by Types in 2017
Table Liraglutide Types for Major Manufacturers
Figure Pills Picture
Figure Liquid Picture
Figure Liraglutide Sales Market Share by Applications in 2017
Figure Hospital Picture
Figure Drug Store Picture
Figure United States Liraglutide Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Liraglutide Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Liraglutide Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Liraglutide Revenue (Value) and Growth Rate (2013-2023)
Figure France Liraglutide Revenue (Value) and Growth Rate (2013-2023)
Figure UK Liraglutide Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Liraglutide Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Liraglutide Revenue (Value) and Growth Rate (2013-2023)
Figure China Liraglutide Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Liraglutide Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Liraglutide Revenue (Value) and Growth Rate (2013-2023)
Figure India Liraglutide Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Liraglutide Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Liraglutide Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Liraglutide Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Liraglutide Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Liraglutide Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Liraglutide Revenue (Value) and Growth Rate (2013-2023)
Table HEC Pharm Basic Information, Manufacturing Base and Competitors
Table HEC Pharm Liraglutide Type and Applications
Table HEC Pharm Liraglutide Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Bachem Basic Information, Manufacturing Base and Competitors
Table Bachem Liraglutide Type and Applications
Table Bachem Liraglutide Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Bharat Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Bharat Pharmaceuticals Liraglutide Type and Applications
Table Bharat Pharmaceuticals Liraglutide Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Kingpep Biotechnology Basic Information, Manufacturing Base and Competitors
Table Kingpep Biotechnology Liraglutide Type and Applications
Table Kingpep Biotechnology Liraglutide Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Shenzhen JYMed Technology Basic Information, Manufacturing Base and Competitors
Table Shenzhen JYMed Technology Liraglutide Type and Applications
Table Shenzhen JYMed Technology Liraglutide Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Wuxi Asiapeptide Basic Information, Manufacturing Base and Competitors
Table Wuxi Asiapeptide Liraglutide Type and Applications
Table Wuxi Asiapeptide Liraglutide Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table AmbioPharm Basic Information, Manufacturing Base and Competitors
Table AmbioPharm Liraglutide Type and Applications
Table AmbioPharm Liraglutide Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Global Liraglutide Sales by Manufacturer (2016-2017)
Figure Global Liraglutide Sales Market Share by Manufacturer in 2016
Figure Global Liraglutide Sales Market Share by Manufacturer in 2017
Table Global Liraglutide Revenue by Manufacturer (2016-2017)
Figure Global Liraglutide Revenue Market Share by Manufacturer in 2016
Figure Global Liraglutide Revenue Market Share by Manufacturer in 2017
Figure Top 3 Liraglutide Manufacturer (Revenue) Market Share in 2017
Figure Top 6 Liraglutide Manufacturer (Revenue) Market Share in 2017
Figure Global Liraglutide Sales and Growth Rate (2013-2018)
Figure Global Liraglutide Revenue and Growth Rate (2013-2018)
Table Global Liraglutide Sales by Regions (2013-2018)
Table Global Liraglutide Sales Market Share by Regions (2013-2018)
Table Global Liraglutide Revenue by Regions (2013-2018)
Figure Global Liraglutide Revenue Market Share by Regions in 2013
Figure Global Liraglutide Revenue Market Share by Regions in 2017
Figure North America Liraglutide Sales and Growth Rate (2013-2018)
Figure Europe Liraglutide Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Liraglutide Sales and Growth Rate (2013-2018)
Figure South America Liraglutide Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Liraglutide Sales and Growth Rate (2013-2018)
Figure North America Liraglutide Revenue and Growth Rate (2013-2018)
Table North America Liraglutide Sales by Countries (2013-2018)
Table North America Liraglutide Sales Market Share by Countries (2013-2018)
Figure North America Liraglutide Sales Market Share by Countries in 2013
Figure North America Liraglutide Sales Market Share by Countries in 2017
Table North America Liraglutide Revenue by Countries (2013-2018)
Table North America Liraglutide Revenue Market Share by Countries (2013-2018)
Figure North America Liraglutide Revenue Market Share by Countries in 2013
Figure North America Liraglutide Revenue Market Share by Countries in 2017
Figure United States Liraglutide Sales and Growth Rate (2013-2018)
Figure Canada Liraglutide Sales and Growth Rate (2013-2018)
Figure Mexico Liraglutide Sales and Growth Rate (2013-2018)
Figure Europe Liraglutide Revenue and Growth Rate (2013-2018)
Table Europe Liraglutide Sales by Countries (2013-2018)
Table Europe Liraglutide Sales Market Share by Countries (2013-2018)
Table Europe Liraglutide Revenue by Countries (2013-2018)
Figure Europe Liraglutide Revenue Market Share by Countries in 2016
Figure Europe Liraglutide Revenue Market Share by Countries in 2017
Figure Germany Liraglutide Sales and Growth Rate (2013-2018)
Figure UK Liraglutide Sales and Growth Rate (2013-2018)
Figure France Liraglutide Sales and Growth Rate (2013-2018)
Figure Russia Liraglutide Sales and Growth Rate (2013-2018)
Figure Italy Liraglutide Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Liraglutide Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Liraglutide Sales by Countries (2013-2018)
Table Asia-Pacific Liraglutide Sales Market Share by Countries (2013-2018)
Figure Asia-Pacific Liraglutide Sales Market Share by Countries 2017
Table Asia-Pacific Liraglutide Revenue by Countries (2013-2018)
Figure Asia-Pacific Liraglutide Revenue Market Share by Countries 2017
Figure China Liraglutide Sales and Growth Rate (2013-2018)
Figure Japan Liraglutide Sales and Growth Rate (2013-2018)
Figure Korea Liraglutide Sales and Growth Rate (2013-2018)
Figure India Liraglutide Sales and Growth Rate (2013-2018)
Figure Southeast Asia Liraglutide Sales and Growth Rate (2013-2018)
Figure South America Liraglutide Revenue and Growth Rate (2013-2018)
Table South America Liraglutide Sales by Countries (2013-2018)
Table South America Liraglutide Sales Market Share by Countries (2013-2018)
Figure South America Liraglutide Sales Market Share by Countries in 2017
Table South America Liraglutide Revenue by Countries (2013-2018)
Table South America Liraglutide Revenue Market Share by Countries (2013-2018)
Figure South America Liraglutide Revenue Market Share by Countries in 2017
Figure Brazil Liraglutide Sales and Growth Rate (2013-2018)
Figure Argentina Liraglutide Sales and Growth Rate (2013-2018)
Figure Colombia Liraglutide Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Liraglutide Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Liraglutide Sales by Countries (2013-2018)
Table Middle East and Africa Liraglutide Sales Market Share by Countries (2013-2018)
Figure Middle East and Africa Liraglutide Sales Market Share by Countries in 2017
Table Middle East and Africa Liraglutide Revenue by Countries (2013-2018)
Table Middle East and Africa Liraglutide Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Liraglutide Revenue Market Share by Countries in 2013
Figure Middle East and Africa Liraglutide Revenue Market Share by Countries in 2017
Figure Saudi Arabia Liraglutide Sales and Growth Rate (2013-2018)
Figure UAE Liraglutide Sales and Growth Rate (2013-2018)
Figure Egypt Liraglutide Sales and Growth Rate (2013-2018)
Figure Nigeria Liraglutide Sales and Growth Rate (2013-2018)
Figure South Africa Liraglutide Sales and Growth Rate (2013-2018)
Table Global Liraglutide Sales by Type (2013-2018)
Table Global Liraglutide Sales Share by Type (2013-2018)
Table Global Liraglutide Revenue by Type (2013-2018)
Table Global Liraglutide Revenue Share by Type (2013-2018)
Figure Global Pills Sales Growth (2013-2018)
Figure Global Pills Price (2013-2018)
Figure Global Liquid Sales Growth (2013-2018)
Figure Global Liquid Price (2013-2018)
Table Global Liraglutide Sales by Application (2013-2018)
Table Global Liraglutide Sales Share by Application (2013-2018)
Figure Global Drug Store Sales Growth (2013-2018)
Figure Global Liraglutide Sales, Revenue and Growth Rate (2018-2023)
Table Global Liraglutide Sales Forecast by Regions (2018-2023)
Table Global Liraglutide Market Share Forecast by Regions (2018-2023)
Figure North America Sales Liraglutide Market Forecast (2018-2023)
Figure Europe Sales Liraglutide Market Forecast (2018-2023)
Figure Asia-Pacific Sales Liraglutide Market Forecast (2018-2023)
Figure South America Sales Liraglutide Market Forecast (2018-2023)
Figure Middle East and Africa Sales Liraglutide Market Forecast (2018-2023)
Table Global Liraglutide Sales Forecast by Type (2018-2023)
Table Global Liraglutide Market Share Forecast by Type (2018-2023)
Table Global Liraglutide Sales Forecast by Application (2018-2023)
Table Global Liraglutide Market Share Forecast by Application (2018-2023)
Table Distributors/Traders/ Dealers List
  • Global Insulin Glargine Market Research Report 2018
    Published: 19-Jun-2018        Price: US 2900 Onwards        Pages: 95
    This report studies the global Insulin Glargine market status and forecast, categorizes the global Insulin Glargine market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, Asia-Pacific, South America, and Middle East & Africa. Insulin glargine, marketed under the names Lantus among others, is a long-acting basal insulin analogue, given once daily to help control the blood sugar level of those with......
  • Global Insulin Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 12-Jun-2018        Price: US 3480 Onwards        Pages: 136
    Insulin is used to treat type 1 diabetes (condition in which the body does not produce insulin and therefore cannot control the amount of sugar in the blood). It is also used to treat people with type 2 diabetes (condition in which the body does not use insulin normally and, therefore, cannot control the amount of sugar in blood) who need insulin to control their diabetes. Nowadays, Insulin as an important drug is widely used to treat diabetes. Scope of the Report: This rep......
  • Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Insulin Market 2018, Forecast to 2023
    Published: 12-Jun-2018        Price: US 4880 Onwards        Pages: 133
    Insulin is used to treat type 1 diabetes (condition in which the body does not produce insulin and therefore cannot control the amount of sugar in the blood). It is also used to treat people with type 2 diabetes (condition in which the body does not use insulin normally and, therefore, cannot control the amount of sugar in blood) who need insulin to control their diabetes. Nowadays, Insulin as an important drug is widely used to treat diabetes. Scope of the Report: This rep......
  • Global Insulin API Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 12-Jun-2018        Price: US 3480 Onwards        Pages: 131
    Insulin is used to treat type 1 diabetes (condition in which the body does not produce insulin and therefore cannot control the amount of sugar in the blood). It is also used to treat people with type 2 diabetes (condition in which the body does not use insulin normally and, therefore, cannot control the amount of sugar in blood) who need insulin to control their diabetes. Nowadays, Insulin as an important drug is widely used to treat diabetes. In China and Chinese insulin market, animal i......
  • Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Insulin API Market 2018, Forecast to 2023
    Published: 12-Jun-2018        Price: US 4880 Onwards        Pages: 128
    Insulin is used to treat type 1 diabetes (condition in which the body does not produce insulin and therefore cannot control the amount of sugar in the blood). It is also used to treat people with type 2 diabetes (condition in which the body does not use insulin normally and, therefore, cannot control the amount of sugar in blood) who need insulin to control their diabetes. Nowadays, Insulin as an important drug is widely used to treat diabetes. In China and Chinese insulin market, animal i......
  • Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Liraglutide Market 2018, Forecast to 2023
    Published: 11-Jun-2018        Price: US 4880 Onwards        Pages: 134
    Liraglutide (NN2211) is a long-acting glucagon-like peptide-1 receptor agonist, binding to the same receptors as does the endogenous metabolic hormone GLP-1 that stimulates insulin secretion. Marketed under the brand name Victoza, it is an injectable drug developed by Novo Nordisk for the treatment of type 2 diabetes. In 2015, Novo Nordisk began marketing it in the U.S. under the brand name Saxenda as a treatment for obesity in adults with at least one weight-related comorbid condition. ......
  • Global Diabetes Drugs Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 06-Jun-2018        Price: US 3480 Onwards        Pages: 149
    Diabetes is a condition that keeps your body from making enough insulin. Insulin is a hormone that's made by an organ called the pancreas. When the body doesn't make enough insulin, sugar builds up in the blood instead of moving to cells and being used for energy. This causes blood sugar to be high. If blood sugar stays high for a long time, it can cause serious health problems - including blindness, kidney damage, heart disease and stroke. That's why it's important to take medicine that helps l......
  • Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Diabetes Drugs Market 2018, Forecast to 2023
    Published: 06-Jun-2018        Price: US 4880 Onwards        Pages: 148
    Diabetes is a condition that keeps your body from making enough insulin. Insulin is a hormone that's made by an organ called the pancreas. When the body doesn't make enough insulin, sugar builds up in the blood instead of moving to cells and being used for energy. This causes blood sugar to be high. If blood sugar stays high for a long time, it can cause serious health problems - including blindness, kidney damage, heart disease and stroke. That's why it's important to take medicine that helps l......
  • 2018-2023 Global Insulin Drug and Delivery Technologies Consumption Market Report
    Published: 05-Jun-2018        Price: US 4660 Onwards        Pages: 136
    In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Insulin Drug and Delivery Technologies market for 2018-2023. Insulin is a protein hormone that is used as a medication to treat high blood glucose. This includes in diabetes mellitus type 1, diabetes mellitus type 2, gestational diabetes, and complications of diabetes such as diabetic ketoacidosis and hyperosmolar hyperglycemic states. It is also used along......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs